The firms analyzed were Cipla, Hikma, Sun Pharma, Teva, and Viatris.
The decision means generic versions of the drug, which is a critical part of shorter regimens for drug-resistant TB, can be made and sold in 134 low- and middle-income countries.
There were no significant differences in risk among COVID patients with chronic conditions and healthy immune systems or older unvaccinated patients.
Infectious disease information from CIDRAP.
Discussion & analysis on the latest infectious disease developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and COVID-19 podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
"All of us know someone who has died from COVID in Minnesota. It's our grandpas and our grandmas, our moms and our dads, our brothers and our sisters and ... even our kids."
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.